Arrowstreet Capital, Limited Partnership Organogenesis Holdings Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 162,405 shares of ORGO stock, worth $735,694. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162,405Holding current value
$735,694% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
140Shares Held
67.8MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$56.5 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M3.28MShares$14.8 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...